Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000947871-25-000042
Filing Date
2025-01-15
Accepted
2025-01-15 17:36:45
Documents
1
Period of Report
2025-01-14

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3921
  Complete submission text file 0000947871-25-000042.txt   5454
Mailing Address C/O ALLOGENE THERAPEUTICS, INC. 210 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address
MESSEMER DEBORAH M. (Reporting) CIK: 0001754424 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41222 | Film No.: 25533821

Mailing Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102
Business Address 301 COMMERCE STREET SUITE 3300 FORT WORTH TX 76102 817-871-4000
TPG Inc. (Issuer) CIK: 0001880661 (see all company filings)

EIN.: 872063362 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 6282 Investment Advice
(CF Office: 02 Finance)